CMR Surgical Limited Sustainability Profile
CMR Surgical Limited, headquartered in the United Kingdom, is a pioneering company in the field of surgical robotics. Founded in 2014, CMR has rapidly established itself as a leader in the medical technology industry, focusing on the development of innovative robotic-assisted surgical systems. The company’s flagship product, the Versius® Surgical Robotic System, is designed to enhance minimally invasive surgery, offering surgeons greater precision and flexibility. CMR's commitment to advancing surgical techniques has positioned it as a key player in the global market, with significant operational presence across Europe and beyond. Notable achievements include securing substantial funding to support research and development, as well as partnerships with leading healthcare institutions. CMR Surgical continues to drive innovation, aiming to transform surgical practices and improve patient outcomes worldwide.
DitchCarbon Score
How does CMR Surgical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CMR Surgical Limited's score of 42 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CMR Surgical Limited's reported carbon emissions
In 2024, CMR Surgical Limited reported total carbon emissions of approximately 105,045,000 kg CO2e. This figure includes Scope 1 emissions of about 25,501,000 kg CO2e and Scope 2 emissions of approximately 69,818,000 kg CO2e (market-based). Notably, the company has not disclosed Scope 3 emissions for 2024, but in 2023, it reported Scope 1 emissions of about 26,828,000 kg CO2e and Scope 2 emissions of approximately 78,217,000 kg CO2e (market-based). CMR Surgical has not set specific reduction targets or initiatives as part of its climate commitments, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi). The absence of reduction targets indicates a potential area for future development in their sustainability strategy. The emissions data is not cascaded from any parent organization, indicating that CMR Surgical Limited is independently reporting its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 26,828,000 | 00,000,000 |
| Scope 2 | 78,217,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 |
How Carbon Intensive is CMR Surgical Limited's Industry?
How Carbon Intensive is CMR Surgical Limited's Location?
CMR Surgical Limited's Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 37% of Scope 3 emissions.
Top Scope 3 Categories
CMR Surgical Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CMR Surgical Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
